Preparation,characterization and in vitro anticoagulation of emodin-eluting controlled biodegradable stent coatings

In this study, emodin-eluting poly(lactide-co-glycolide) (PLGA) coating stents and emodin-loaded PLGA films were prepared to explore the potential application of emodin-eluting stent for treating cardiovascular disease. Fourier transform infrared spectra (FTIR) showed all characteristic adsorption peaks of emodin in emodin-loaded PLGA film in comparison to pure emodin. The balloon expansion experiment and surface morphology observation suggested that the integrated emodin-eluting coatings were successfully obtained on the stainless steel surfaces and the coatings had the ability to withstand the strains imparted during balloon experiment. The drug release profile revealed the nearly linear release curve without obvious burst release for different doses of emodin-eluting stents. As compared with stainless steel and PLGA, in vitro platelet adhesion and APTT (activated partial thromboplastin time) tests revealed better blood compatibility of emodin-eluting stent. In conclusion, the results of the present study showed that the emodin-eluting stent has a potential application for treating cardiovascular disease.     

Platelet adhesion and protein adsorption on silicone rubber surface by ozone-induced grafted polymerization with carboxybetaine monomer

Platelet adhesion and protein adsorption on the silicone rubber film grafted with N,N'-dimethyl-N-methacryloyloxyethyl-N-(2-carboxyethyl) ammonium (DMMCA) was studied. The grafting was carried out by means of ozone-induced method and was confirmed by ATR-FTIR and XPS investigations. The grafted films possessed relatively hydrophilic surface revealed by contact angle measurement. The blood compatibility of the grafted film was evaluated in vitro by platelet adhesion in platelet-rich plasma (PRP) and protein absorption in bovine fibrinogen (BFG) using silicone film as the reference. No substantial platelet adhesion was observed for the grafted films incubated in PRP for 60 and 180 min. The protein absorption was also significantly reduced after incubated in bovine fibrinogen for 60 min. Both the results indicated that the blood compatibility of silicone rubber was greatly improved by ozone-induced grafting of carboxybetaine zwitterionic polymer onto its surface.     

316L钢表面纳米银镀层的制备、性质及血液相容性

采用恒电位电沉积方法在316L不锈钢表面沉积银纳米镀层, 并将钢板置于全氟硅烷溶液中浸泡, 通过动态凝血实验、 抗凝血时间测定、 血小板黏附实验、 溶血实验和蛋白吸附实验等手段, 测试材料的血液相容性. 结果表明, 通过上述方法可明显改善316L不锈钢的血液相容性, 而抗凝血性能、 溶血率及纤维蛋白吸附量不亚于裸钢板. 与316L裸不锈钢相比, 银镀膜全氟硅烷浸泡316L不锈钢具有良好的血液相容性, 是一种比较理想的冠状动脉支架材料, 具有良好的应用前景.     

Controllable biodegradability, drug release behavior and hemocompatibility of PTX-eluting magnesium stents

Cardiovascular magnesium-based stents have been already applied in patients. However, their high corrosion rate hinders their clinical application. In this study, we adopt a new approach in the design of a Mg-based stent to improve the biodegradation rate and the drug release rate. By fabricating a micro-arc oxidation/poly-l-lactic acid (MAO/PLLA) composite coating on the magnesium alloy AZ81 substrate, the corrosion resistance decreased and the biodegradation rate became controllable. The drug release coating was composed of one Poly(dl-lactide-co-glycolide)/paclitaxel (PLGA/PTX) layer and one pure PLGA blank layer without paclitaxel, and this coating also functions to provide controlled biodegradation rate of the stent. The drug release rate was controlled by controlling the ratio of the LA:GA of the PLGA without PTX. The scanning electron microscopy (SEM) images were used to demonstrate the morphology of the samples before and after this modification. The blood compatibility of the samples was demonstrated by the platelet adhesion test. The drug release was determined by ultraviolet-visible (UV-visible) spectrophotometer. The result showed that the PLLA effectively sealed the micro-cracks and micro-holes on the surface of the MAO coating to give controllable biodegradation of the AZ81. The drug release rate of PTX exhibited a nearly linear sustained-release profile with no significant burst releases that would come from the uncontrolled oxidation/corrosion of AZ81. The samples modified had better hemocompatibility than 316L stainless steel.     

Surface modification of SPEU films by ozone induced graft copolymerization to improve hemocompatibility

Surface modification of segmented poly(ether urethane) (SPEU) by graft copolymerization with N,N′-dimethyl-N-methacryloyloxyethyl-N-(3-sulfopropyl) ammonium (DMMSA), a zwitterionic sulfobetaine structure, was conducted. A simple two-step procedure for grafting of DMMSA onto the surface of SPEU film was used. The surface was first treated with ozone to introduce active hydroperoxide groups. The active surface was then exposed to the DMMSA solution in the sealed tube. Grafted SPEU film was characterized by ATR–FTIR, XPS and contact angle measurement. ATR–FTIR and XPS investigations confirmed the graft copolymerization. The monomer concentration, copolymerization temperature and time were varied to maximize the efficiency of DMMSA grafting. The equilibrium water content (EWC) and contact angle measurements showed that the hydrophilicity of the film had been greatly improved. The blood compatibility of the grafted films was evaluated by platelet adhesion in platelet rich plasma (PRP), deposits in blood control and protein adsorption in bovine fibrinogen using SPEU film as the control. No platelet adhesion and no thrombus were observed for the grafted films incubated in PRP for 300 min and in blood for 120 min, respectively. The protein adsorption was reduced on the grafted films after incubation in bovine fibrinogen for 120 min. These results proved that improved blood compatibility was obtained by grafting this new zwitterionic sulfobetaine structure monomer onto SPEU film.     

Blood compatibility of polyurethane surface grafted copolymerization with sulfobetaine monomer

Surface modification is an effective way to improve the hemocompatibility and remain bulk properties of biomaterials. Recently, polymer tailed with zwitterions was found having good blood compatibility. In this study, the grafting copolymerization of sulfobetaine onto polyurethane surface was obtained through two steps. In the first step, polyurethane film coupled with vinyl groups was obtained through the reaction between the carboxyl group of acrylic acid (AA) and the NH-urethane group of polyurethane by dicyclohexylcarbodiimide (DCC). In the second step, sulfobetaine was grafted copolymerization on the surface using AIBN as an initiator. The reaction process was monitored with ATR-IR spectra and X-ray photoelectron spectroscopy (XPS) spectra. The wettability of films was investigated by water contact angle measurement. The blood compatibility of the grafted films was evaluated by platelet adhesion in platelet rich plasma (PRP) and protein absorption in bovine fibrinogen (BFG). Low platelet adhesion was observed on the grafted films incubated in PRP for 1 and 3 h, respectively. The protein absorption was reduced on the grafted films after incubated in bovine fibrinogen for 2 h. All of these results revealed that the improved blood compatibility was obtained by grafting copolymerization with zwitterionic monomer of sulfobetaine onto polyurethane film. In addition, introducing vinyl groups onto surface through DCC and AA is a novel method to functionalize polyurethane for further modification.     

白蛋白原位复合的生物医用功能材料的研究(Ⅱ)──白蛋白的选择性吸附和血液相容性研究

采用¹²⁵I放射标记技术研究了血浆白蛋白和纤维蛋白原在聚甲基丙烯酸甲酯-接枝-十八烷基聚氧乙烯(PMMA-g-SPEO)、聚甲基丙烯酸甲酯-接枝-乙基聚氧乙烯(PMMA-g-EPEO)和聚甲基丙烯酸甲酯-甲基丙烯酸十八酯共聚物(PMMA-co-SMA)表面的竞争吸附行为.结果表明,十八烷基聚氧乙烯复合修饰的PMMA-g-SPEO可高选择性地形成白蛋白可逆吸附层,有效地阻抗血小板的粘附,延长材料的凝血时间,是一种理想的白蛋白原位复合的生物医用功能材料.     

Protein adsorption and platelet adhesion of polysulfone membrane immobilized with chitosan and heparin conjugate

Polysulfone (PSF) membranes were treated with ozone to introduce peroxides, and then grafted with either acrylic acid or chitosan, followed by the immobilization of heparin. The effect of spacer arm on blood compatibility was investigated using three chitosans of different molecular weight [1170 (water soluble), 160 000, and 400 000] and similar degrees of deacetylation (75%). The hydrophilicity was evaluated by measuring the contact angle of water. Blood compatibility was evaluated using the activated partial thromboplastin time (APTT) as well as the adhesion of platelets. The protein affinity was determined by the absorption of human serum albumin (HSA) and human plasma fibrinogen (HPF). The results show that by the coupling of chitosan, the amount of heparin immobilized can be increased by four times. Water contact angle (from 78 ° to 41 °) decreased with the increase of the amount of heparin immobilized, showing increased wettability. The heparinized PSF membrane showed longer APTT and decreasing platelet adhesion, compared to that of unmodified PSF membrane. The adsorption of HSA and HPF were reduced to 17 and 6%, respectively. This suggests that longer spacer binding to heparin can increase the opportunity of anti‐coagulation on contacting blood. These results demonstrated that the hydrophilicity and blood compatibility of PSF membrane could be improved by chitosan and heparin conjugate. Copyright © 2003 John Wiley & Sons, Ltd.     

A Commercial Nonbinding Surface Effectively Reduces Fibrinogen Adsorption but Does Not Prevent Platelet Adhesion to Fibrinogen

A commercial nonbinding surface effectively prevents protein adsorption; however, the platelet phenotype on this surface has yet to be defined. This study evaluates platelet adhesion and adsorption of several plasma/extracellular matrix (ECM) proteins to the nonbinding surface compared to other commonly used nontreated and high-binding surfaces. Platelet adhesion to uncoated microplates and those coated with fibrinogen or collagen is quantified by colorimetric assay. The binding capacity of the examined surfaces for plasma/ECM proteins is evaluated by measuring the relative and absolute protein adsorption. Compared to other surfaces, the nonbinding surface effectively prevents platelet adsorption, i.e. by 61-93% (Enzyme-Linked Immunosorbent Assay, ELISA), and reduces platelet adhesion, i.e. by 92%, when not coated with any protein. The nonbinding surface also decreases platelet deposition on collagen (up to 31%), but not fibrinogen. The nonbinding surface seems to be more of a low-fouling than nonfouling material, as it is able to reduce fibrinogen adsorption but not prevent platelet adhesion to fibrinogen. This feature should be considered when using the nonbinding surface for in vitro platelet testing.     

基于多巴胺自聚合及肝素固定改善钛的血液相容性

利用多巴胺自聚合及肝素固定的方法对纯钛进行表面修饰, 以改善其血液相容性. 采用水接触角测量、 X射线光电子能谱(XPS)和甲苯胺蓝法(TBO)等方法对所修饰的材料进行了表征. 采用溶血实验检测了材料的溶血性能, 并结合活化部分凝血活酶时间(APTT)测试和血小板黏附实验对所修饰材料的血液相容性进行了评价. 结果表明, 多巴胺能够在钛表面实现自聚合, 肝素可以共价接枝在聚多巴胺层上, 经肝素修饰后的材料的表面亲水性显著提高, 而且具有较低的溶血率, APTT时间显著延长, 血小板的黏附数量和被激活程度也显著降低. 因此, 纯钛经多巴胺自聚合以及肝素接枝修饰后的血液相容性得到了显著改善, 有望成为具有抗凝血功能的新型心血管植入材料.     

New biocompatible polypyrrole-based films with good blood compatibility and high electrical conductivity

A novel O-butyryl chitosan (OBCS)-grafted polypyrrole (PPy) film was described. The immobilization was accomplished by photocrosslinking the OBCS onto PPy films under ultraviolet light irradiation. The surfaces of OBCS-grafted PPy film were characterized by attenuated total reflection Fourier transform infrared (ATR-FTIR) spectroscopy and electron spectroscopy for chemical analysis (ESCA). The blood compatibility of the OBCS-grafted PPy film was evaluated by platelet-rich plasma (PRP) contacting experiments and protein adsorption experiments in vitro. These results have demonstrated that the surface with immobilized OBCS shows much less platelet adhesive and fibrinogen adsorption compared to the control surface. The bulk conductivity values of PPy films were measured by a modified four-probe method. The composite films have both good blood compatibility and high electrical conductivity that make them suitable for using as potential biomaterials, such as electrically conducting blood vessel and functionally haemocompatible substrate of biosensor used directly in whole blood.     

Blood compatibility of surface-engineered poly(ethylene terephthalate) via o-carboxymethylchitosan

Poly(ethylene terephthalate) (PET) films were treated by argon plasma following by graft copolymerization with acrylic acid (AAc). The obtained PET-surface grafted PAA (PET-g-PAA) was coupled with chitosan (CS) and o-carboxymethylchitosan (OCMCS) molecules, respectively. Their surface physicochemical properties were characterized by X-ray photoelectron spectroscopy (XPS), water contact angle and streaming potential measurements. The PET-g-PAA surface containing carboxylic acid, CS immobilized PET surface containing amino and OCMCS immobilized PET surface containing both carboxylic acid and amino groups, make the PET surface exhibited a hydrophilic character. The blood compatibility was evaluated by platelet contacting experiments and protein adsorption experiments in vitro. The results demonstrate that the PET surface coupling OCMCS shows much less platelet adhesive and fibrinogen adsorption compared to the other surface modified PET films. The anticoagulation of PET-OCMCS is ascribed to the suitable balance of hydrophobicity/hydrophilicity, surface zeta potential and the low adsorption of protein.     

Preparation and in vitro release profiles of drug-eluting controlled biodegradable polymer coating stents

In the present study, the different drug-eluting controlled biodegradable polymer coatings were fabricated on stainless steel stents. The coatings were not only uniform and smooth but also had excellent mechanical property. The drug release profiles of drug-eluting stents were studied in detail in this study. Depending on the drug type, different drug-eluting stents exhibited different drug release profile. There were two basic release profiles for different drug-eluting stents, i.e., two-phase release profile with burst release or linear release profile without burst release. Incorporating heparin in the rapamycin or curcumin eluting stents can improve the average drug release rate of both and the burst release of rapamycin. The average drug release rate increased with the increase of drug loading but was not proportional to increase of the ratio of drug/polymer. Fabricating the control release layer on rapamycin-eluting stent surface can prevent the burst release of rapamycin and prolong the release period of rapamycin. All results showed that the drug release profile of drug-eluting stents depends on many parameters including drug type, ratio of drug/polymer, and drug carrier properties.     

Effect of immobilization of polysaccharides on the biocompatibility of poly(butyleneadipate‐co‐terephthalate) films

Aiming to improve the hydrophilicity, antibacterial activity, cytocompatibility, and hemocompatibility of poly(butyleneadipate‐co‐terephthalate) (PBAT) films, PBAT films were treated with ozone, grafted with chitosan (CS), and followed by covalent immobilization of either heparin (HEP) or hyaluronic acid (HA). The surface graft density of modified PBAT films was detected by X‐ray photoelectron spectroscopy (XPS) and dyeing. The surface roughness of PBAT films was measured using an atomic force microscope (AFM). After immobilizing CS, PBAT films acquired antibacterial activity against Staphylococcus aureus and Escherichia coli. The adsorption of human serum albumin (HSA) and human plasma fibrinogen (HPF) on PBAT–CS–HEP and PBAT–CS–HA films was lower compared to that of native PBAT. Moreover, HEP immobilization could effectively reduce platelet adhesion and prolong the blood coagulation time, thereby improving the blood compatibility of PBAT. In addition, the growth of L929 fibroblasts was improved for HEP or HA immobilized PBAT, suggesting this surface modification was non‐cytotoxic. Furthermore, PBAT–CS–HEP and PBAT–CS–HA exhibited higher cell proliferation than native PBAT. Copyright © 2009 John Wiley & Sons, Ltd.     

Preparation of block copolymer of poly(trimethylene carbonate) with oligo(ethylene glycol) and the surface properties of the dip coated film

To persuade the stent coating materials for the better sustainable development, a block copolymer composed of hydrophobicity of poly(trimethylene carbonate) (PTMC) and hydrophilicity of PTMC bearing ethylene glycol chains was synthesized as a potential candidate. The result of thermal stability of the polymer was analyzed which reached up to 206 °C (T₁₀) and it is considered that sufficient for sterilization during the treatment. Moreover, the dip coated films of polymer were coated on polyethylene (PE) and stainless steel (SS) substrates in order to stimulate the stability upon the physiological environment. In addition, the preliminary in vitro test of the films were evaluated by protein adsorption and blood platelet adhesion tests. Hence, this study tends to convince that the synthetic block copolymer based on PTMC derivatives were approached for stent coating materials.     

Improvement of interfacial adhesion of biodegradable polymers coated on metal surface by nanocoupling

A method of securing the adhesion of biodegradable polymer coating was investigated for drug-eluting metal stents, using surface-initiated ring-opening polymerization (SI-ROP) of L-lactide. Introduction of oligolactide on the stainless steel (SS) surface was successful and the thickness of the oligolactide grafts remained on the nanometer scale, as determined by ellipsometry. The presence of an oligolactide graft was also identified using attenuated total reflection-Fourier transform infrared (ATR-FTIR) and electron spectroscopy for chemical analysis (ESCA). On top of the grafts, poly(D,L-lactide-co-glycolide) (PLGA) coating was carried out on different substrates such as SS control, plasma-treated SS, and lactide-grafted (referred to as a nanocoupled) SS using electrospraying. When the adhesion forces were measured with a scratch tester, the nanocoupled SS showed the strongest interfacial adhesion between polymer coating layer and metal substrate. The outcome of the peel-off test was also consistent with the result of the scratch test. When degradation behavior of the polymer coating in vitro was examined for up to 4 weeks in a continuous fluid flow, the SEM images demonstrated that polymer degradation was obvious due to hydration and swelling of the polymer matrix. Although the matrix completely disappeared after 4 weeks for SS control and plasma-treated substrates, the nanocoupled SS was persistent with some polymer matrix. In addition, the release profiles of SRL-loaded PLGA coating appeared slightly different between control and nanocoupled groups. This work suggested that the concept of nanocoupling remarkably improved the interfacial adhesion stability between metal surface and polymer layer and controlled drug release, and showed the feasibility of drug-eluting stents.     

Comparison of Gelatin/Polylysine- and Silk Fibroin/SDF-1α-Coated Mesenchymal Stem Cell-Seeded Intracranial Stents

Endothelialization of the aneurysmal neck is essential for aneurysm healing after endovascular treatment. Mesenchymal stem cell (MSC)-seeded stents can promote aneurysm repair. The biological effects of coated and uncoated nitinol intracranial stents seeded with MSCs on vascular cells and macrophage proliferation and inflammation are investigated. Two stent coatings that exert pro-aggregation effects on MSCs via different mechanisms are examined: gelatin/polylysine (G/PLL), which enhances cell adhesion, and silk fibroin/SDF-1α (SF/SDF-1α), which enhances chemotaxis. The aim is to explore the feasibility of MSC-seeded coated stents in the treatment of intracranial aneurysms. The G/PLL coating provides the highest cytocompatibility and blood compatibility substrate for MSCs and vascular cells and promotes cell adhesion and proliferation. Moreover, it enhances MSC secretion and regulation of vascular cell and macrophage proliferation and chemotaxis. Although the SF/SDF-1α coating promotes MSC secretion and vascular cell chemotaxis, it induces a greater degree of macrophage proliferation, chemotaxis, and secretion of pro-inflammatory factors. MSC-seeded stents coated with G/PLL may benefit stent surface endothelialization and reduce the inflammatory response after endovascular treatment of intracranial aneurysm. These effects may improve aneurysm healing and increase the cure rate.     

Surface modification of polyurethane for enhanced blood compatibility

Surfaces of commercial polyurethanes (PUs) were modified by poly(ethylene oxide) (PEO) grafting and/or heparin immobilization or sulfonation to investigate the effect to antithrombogenicity. The hydrophilicity of the modified PUs surface was significantly increased. All the PEO-grafted PU surfaces displayed very little platelet adhesion and activation. The coupled heparin or sulfonate at the end of PEO exhibited anticoagulant activity to extend APTT. Lowering in vitro platelet adhesion of modified PUs led to a prolongation in the ex vivo occlusion time. In particular, the sulfonated PU-PEO surface showed the most enhanced blood compatibility due to the synergistic effects of PEO and SO₃ groups.     

Colloid probe AFM investigation of interactions between fibrinogen and PEG-like plasma polymer surfaces

Interaction forces between surfaces designed to be protein resistant and fibrinogen (Fg) were investigated in phosphate-buffered saline with colloid probe atomic force microscopy. The surfaces of the silica probes were coated with a layer of fibrinogen molecules by adsorption from the buffer. The technique of low-power, pulsed AC plasma polymerization was used to make poly(ethylene glycol) (PEG)-like coatings on poly(ethylene teraphthalate) by using diethylene glycol vinyl ether as the monomer gas. The degree of PEG-like nature of the films was controlled by use of a different effective plasma power in the chamber for each coating, ranging from 0.6 to 3.6 W. This produced a series of thin films with a different number of ether carbons, as assessed by X-ray photoelectron spectroscopy. The interaction force measurements are discussed in relation to trends observed in the reduction of fibrinogen adsorption, as determined quantitatively by (125)I radio-labeling. The plasma polymer coatings with the greatest protein-repelling properties were the most PEG-like in nature and showed the strongest repulsion in interaction force measurements with the fibrinogen-coated probe. Once forced into contact, all the surfaces showed increased adhesion with the protein layer on the probe, and the strength and extension length of adhesion was dependent on both the applied load and the plasma polymer surface chemistry. When the medium was changed from buffer to water, the adhesion after contact was eliminated and only appeared at much higher loads. This indicates that the structure of the fibrinogen molecules on the probe is changed from an extended conformation in buffer to a flat conformation in water, with the former state allowing for stronger interaction with the polymer chains on the surface. These experiments underline the utility of aqueous surface force measurements toward understanding protein-surface interactions, and developing nonfouling surfaces that confer a steric barrier against protein adsorption.     

Interaction of PLGA nanoparticles with human blood constituents

When nanoparticles are injected into the blood for drug delivery or drug detoxification, detrimental interaction of these particles with blood constituents must be avoided. In previous studies, the adsorption of albumin immunoglobulin G, and fibrinogen from blood plasma to a model hydrophobic polymer like polystyrene was investigated as was decreasing surface hydrophobicity, which quantitatively leads to decreasing amounts of adsorbed proteins on latex particles. However, the uptake of other blood constituents, such as inorganic blood electrolytes, by particles and the dispersion/coagulation characteristics of these particles in the blood stream have not been fully studied. Most importantly, the effect s of these particles on blood coagulation and hemolysis are not well known. In the present study, the poly(lactide-co-glycolide) acid(PLGA) nanoparticles were synthesized by using nanoprecipitation. The uptake of blood electrolytes from simulated blood fluid (SBF) and the stability (dispersion/aggregation) of nanoparticles in SBF was examined by using different loading amounts of PLGA and different contact time between PLGA nanoparticles and SBF. The interaction of particles with the organic components of blood was also studied by using the measurement of red blood cell hemolysis and blood clotting with raw PLGA, surfactant modified PLGA, and PEGylated PLGA.